“…With the development of genetic therapy, clinical diagnosis and molecular biology, SNP is regarded as not only a genetic marker in the study of cancer-related drug metabolism or reactivity, but also a fundamental tool in the identification of inherited disease-causing genes (Imyanitov et al, 2004;McCarthy and Hilfiker, 2000;Sidransky, 2002;Sauna, 2007). Therefore, great efforts have been devoted to developing technique methods for screening SNP, such as allele specific oligonucleotide hybridization (Ding et al, 2010;Liu et al, 2005;Liu and Lin, 2007), endonuclease digestion (Gaylord et al, 2005;Li and Liu, 2009), primer extension (Duan et al, 2009a;Litos et al, 2009;Nelson et al, 1996), oligonucleotide ligation (Huh et al, 2009;Lowe et al, 2010;Xue et al, 2009), nonenzymatic ligation (Xu et al, 2001), DNA-specific redox indicators and conjugated mediators (Drummond et al, 2003;Kelley et al, 1999), in combination with fluorescence (FL) (Duan et al, 2007;Guo et al, 2010;Liu et al, 2009;Wang and Liu, 2007), electrochemistry (Kerman et al, 2004;, chemiluminescence (Liu et al, 2006), colorimetry (He et al, 2010a,b;Lee et al, 2010), and mass spectrometry (Mattes and Seitz, 2001) as signal readout.…”